TRIM proteins in hepatocellular carcinoma

K Lu, Y Pan, Z Huang, H Liang, Z Ding… - Journal of biomedical …, 2022 - Springer
The tripartite motif (TRIM) protein family is a highly conserved group of E3 ligases with 77
members known in the human, most of which consist of a RING-finger domain, one or two B …

Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases

PD Talukdar, U Chatterji - Signal Transduction and Targeted Therapy, 2023 - nature.com
Specific cell states in metazoans are established by the symphony of gene expression
programs that necessitate intricate synergic interactions between transcription factors and …

Readout of histone methylation by Trim24 locally restricts chromatin opening by p53

L Isbel, M Iskar, S Durdu, J Weiss, RS Grand… - Nature Structural & …, 2023 - nature.com
The genomic binding sites of the transcription factor (TF) and tumor suppressor p53 are
unusually diverse with regard to their chromatin features, including histone modifications …

BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML

B Kumar, A Singh, R Basar, N Uprety, Y Li… - Science translational …, 2024 - science.org
Myelodysplastic syndrome and acute myeloid leukemia (AML) belong to a continuous
disease spectrum of myeloid malignancies with poor prognosis in the relapsed/refractory …

NOS inhibition sensitizes metaplastic breast cancer to PI3K inhibition and taxane therapy via c-JUN repression

T Reddy, A Puri, L Guzman-Rojas, C Thomas… - Nature …, 2024 - nature.com
Metaplastic breast cancer (MpBC) is a highly chemoresistant subtype of breast cancer with
no standardized therapy options. A clinical study in anthracycline-refractory MpBC patients …

Retinoblastoma-associated protein is important for TRIM24-mediated activation of the mTOR signaling pathway through DUSP2 action in prostate cancer

D Ren, W Li, R Zeng, X Liu, H Liang, W Xiong… - Cell Death & …, 2024 - nature.com
RB transcriptional corepressor 1 (RB) deletion is the most important genomic factor
associated with the prognosis of castration-resistant prostate cancer (CRPC) patients …

Proteolysis Targeting Chimera (PROTAC) as a promising novel therapeutic modality for the treatment of triple‐negative breast cancer (TNBC)

GM Dogheim, MT Amralla - Drug Development Research, 2023 - Wiley Online Library
Breast cancer (BC) is considered one of the most prevalent malignancies impacting women
worldwide, constituting 15% of all new cancer cases. It is classified according to its …

TRIM24 Cooperates with Ras Mutation to Drive Glioma Progression through snoRNA Recruitment of PHAX and DNA‐PKcs

C Xu, G Chen, B Yu, B Sun, Y Zhang… - Advanced …, 2024 - Wiley Online Library
The factors driving glioma progression remain poorly understood. Here, the epigenetic
regulator TRIM24 is identified as a driver of glioma progression, where TRIM24 …

USP7 inhibits the progression of nasopharyngeal carcinoma via promoting SPLUNC1-mediated M1 macrophage polarization through TRIM24

H Liu, L Tang, S Gong, T Xiao, H Yang, W Gu… - Cell Death & …, 2023 - nature.com
Reprogramming of macrophages toward an M1 phenotype is a novel strategy to induce
anticancer immunity. However, the regulatory mechanisms of M1 macrophage polarization …

[HTML][HTML] Latest Therapeutical Approaches for Triple-Negative Breast Cancer: From Preclinical to Clinical Research

M Pont, M Marqués, A Sorolla - International Journal of Molecular …, 2024 - mdpi.com
Triple-negative breast cancer (TNBC) represents roughly one-sixth of all breast cancer
patients, but accounts for 30–40% of breast cancer deaths. Due to the lack of typical …